In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...

Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...

Enanta Pharmaceuticals (NASDAQ:ENTA) announced on Wednesday a lawsuit filed in the EU against Pfizer (NYSE:PFE) and some of ...

By Michael Erman (Reuters) - A 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according a study by Stanford University researchers. Currently, ...

2:20 Health Canada approves Paxlovid, Pfizer’s COVID-19 pill As Paxlovid has become more widely used, some patients have reported that COVID-19 symptoms recurred after completing treatment and ...

Pfizer is committed to working toward equitable access to our oral COVID-19 treatment, PAXLOVID, for high-risk patients in need. Pfizer has established a comprehensive strategy in close partnership ...

Pfizer's CEO Albert Bourla said the company was working directly with Chinese authorities who have shown “tremendous interest” in the treatment. “We are sending as much Paxlovid as we can ...

Paxlovid, which combines a new Pfizer pill with the old antiviral ritonavir, is currently authorized for use in the first days of a COVID infection to prevent severe disease in high-risk patients.

An antiviral drug being hailed for its potential role in the treatment of COVID-19 is now available in Ontario, but doctors warn it comes with significant challenges including low supply. Around ...

Pfizer’s Paxlovid pill not a replacement for COVID-19 vaccine, officials say By Staff The Canadian Press Posted January 18, 2022 8:41 am Updated January 18, 2022 1:00 pm ...

Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...